PlexBio Co (ROCO:6572) Research & Development: NT$52.5 Mil (TTM As of Dec. 2025)


ROCO:6572 PlexBio Co Ltd ROCO:6572
67 GF Score
Price NT$7.62
GF Value NT$9.52
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PlexBio Co Research & Development?

PlexBio Co ROCO:6572 67 Research & Development is NT$52.5 Mil as of Dec. 2025. GuruFocus rates ROCO:6572 with a GF Score™ of 67/100 and a GF Value™ of NT$9.52 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PlexBio Co's Research & Development for the six months ended in Dec. 2025 was NT$25.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$52.5 Mil.

PlexBio Co  (ROCO:6572) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PlexBio Co Research & Development Related Terms

PlexBio Co Research & Development Historical Data

* Premium members only.

The historical data trend for PlexBio Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PlexBio Co Research & Development Chart

PlexBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 113.31 72.61 62.97 69.29 52.50

PlexBio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.37 38.65 30.64 27.05 25.46
ROCO:6572
67GF Score
PlexBio Co Ltd ROCO:6572
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PlexBio Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$52.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$52.5 Mil mean?
PlexBio Co (ROCO:6572) has a Research & Development of NT$52.5 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on PlexBio Co and its competitors.
Is PlexBio Co's Research & Development too high?
PlexBio Co's current Research & Development is NT$52.5 Mil. Overall, PlexBio Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PlexBio Co's Research & Development compare to ABT and SYK?
PlexBio Co's Research & Development of NT$52.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PlexBio Co and its competitors. PlexBio Co's current Research & Development is NT$52.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PlexBio Co stock overvalued right now?
Based on GuruFocus' analysis, PlexBio Co (ROCO:6572) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$9.52, compared to a current price of NT$7.62 — trading 20% below its estimated fair value. The current Research & Development is NT$52.5 Mil. PlexBio Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PlexBio Co (ROCO:6572), the current Research & Development is NT$52.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PlexBio Co (ROCO:6572) Overvalued in 2026?

Based on GuruFocus' analysis, PlexBio Co stock appears to be undervalued. The current stock price of NT$7.62 is trading 20% below its estimated GF Value™ of NT$9.52. GuruFocus considers PlexBio Co to be Modestly Undervalued.

Key valuation signals for ROCO:6572:

  • Research & Development: NT$52.5 Mil
  • GF Value™: NT$9.52 vs. price of NT$7.62 (20% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PlexBio Co Business Description

Address 6F-1, Number 351, Yangguang Street, Neihu District, Taipei, TWN, 11491
PlexBio Co Ltd is a Taiwan based company involved in designing, developing and manufacturing IVD products and instrumentations. Its products are used in companion diagnostic panel, early cancer detection screening, prenatal diagnostics and for food and safety testing.
67GF Score

Get the complete analysis for ROCO:6572

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.62
Price
NT$9.52
GF Value